Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, November 04, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the continued strong sales performance of the antifungal Cresemba® (isavuconazole) by its license partner Pfizer Inc. in Europe exceeded the threshold triggering a USD 30 million sales milestone payment.
  
      BSLN
      globenewswire.com
      • Nov. 4, 2025
  
    
  
  Basel, November 4, 2025 – Novartis will present new data from 33 abstracts across its Cardiovascular, Renal, and Metabolic (CRM) disease portfolio at the upcoming American Society of Nephrology (ASN) Kidney Week 2025 in Houston, Texas and American Heart Association's (AHA) Scientific Sessions 2025 in New Orleans, Louisiana, advancing scientific insight into these critical disease areas. “Novartis will present a broad range of data at ASN and AHA demonstrating innovation and commitment to advancing therapies that address root causes of heart and kidney conditions,” said Ruchira Glaser, M.D., Global Head, Cardiovascular, Renal and Metabolic Development Unit, Novartis. "Studies on both our approved and investigational therapies in these closely connected therapeutic areas reflect our longstanding dedication to deliver meaningful solutions for patients living with some of the rarest to most prevalent CRM diseases worldwide.” Key highlights of data accepted by ASN include:
  
      NVS
      globenewswire.com
      • Nov. 4, 2025
  
    
  
  Fresenius Medical Care reported a third-quarter operating income that exceeded analysts' expectations on Tuesday, in a sign that the dialysis specialist's cost-cutting measures were beginning to take hold.
  
      FMS
      reuters.com
      • Nov. 4, 2025
  
    
  
  Palantir Technologies Inc. ( PLTR ) Q3 2025 Earnings Call November 3, 2025 5:00 PM EST Company Participants Ana Soro Ryan Taylor - Chief Revenue Officer & Chief Legal Officer Shyam Sankar - CTO & Executive VP David Glazer - CFO & Treasurer Alexander Karp - Co-Founder, CEO & Director Conference Call Participants Daniel Ives - Wedbush Securities Inc., Research Division Mariana Perez Mora - BofA Securities, Research Division Presentation Ana Soro Good afternoon. I'm Ana Soro from Palantir's finance team, and I'd like to welcome you to our third quarter 2025 earnings call.
  
      PLTR
      seekingalpha.com
      • Nov. 4, 2025
  
    
  
  Novo Nordisk's new CEO is set to face intense investor scrutiny this week as the Wegovy-maker shakes up its board and pursues a bidding war with U.S. rival Pfizer.
  
      PFE
      reuters.com
      • Nov. 4, 2025
  
    
  
  November 4, 2025 Q3 2025 Group Highlights Comparable order intake growth 8% Group sales amounted to EUR 4.3 billion, reflecting 3% increase in comparable sales Income from operations was EUR 330 million Adjusted EBITA margin increased by 50 basis points to 12.3% of sales Operating cash flow of EUR 327 million, with a free cash flow of EUR 172 million Philips reiterates full-year 2025 outlook, with margin now expected at the upper end of the range Roy Jakobs, CEO of Royal Philips: “In this quarter we maintained our momentum, with AI-powered innovations and long-term partnerships making a real difference for patients and consumers. We drove strong order intake and accelerated sales growth, with sustained strength in North America.
  
      PHG
      globenewswire.com
      • Nov. 4, 2025
  
    
  
  WISeKey and Swiss Armed Forces Advance Quantum-Secure Satellite Security Geneva and Bern, Switzerland – November 4, 2025 – WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading Swiss cybersecurity, AI, and IoT company, together with its subsidiaries WISeSat.Space which focuses on space technology for secure satellite communication, and SEALSQ Corp (NASDAQ: LAES), ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today provided an update on the evolution of its collaboration with the Swiss Armed Forces (SAF). This partnership, initiated in 2022, continues to advance Switzerland's sovereign space and cybersecurity infrastructure by combining secure IoT satellites with trusted digital identity and post-quantum cryptographic technologies.
  
      QMCO
      globenewswire.com
      • Nov. 4, 2025
  
    
  
  Geneva, Switzerland, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, together with its parent company WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading Swiss cybersecurity, AI, and IoT company, and WISeSat.Space which focuses on space technology for secure satellite communication, today provided an update on the evolution of its collaboration with the Swiss Armed Forces (SAF). This partnership, initiated in 2022, continues to advance Switzerland's sovereign space and cybersecurity infrastructure by combining secure IoT satellites with trusted digital identity and post-quantum cryptographic technologies.
  
      LAES
      globenewswire.com
      • Nov. 4, 2025
  
    
  
  Immune response successfully improved with second generation vaccine candidate Saint-Herblain (France), November 4, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced positive results of its Phase 1 clinical trial investigating the safety and immunogenicity of VLA1601, its second-generation adjuvanted inactivated vaccine candidate against the Zika virus (ZIKV). The randomized controlled Phase 1 trial, VLA1601-102, enrolled approximately 150 participants aged 18 to 49 years in the United States.
  
      VALN
      globenewswire.com
      • Nov. 4, 2025
  
    
  
  Nokia CorporationStock Exchange Release4 November 2025 at 08:00 EET Nokia announces intention to seek a delisting from Paris Stock Exchange
  
      NOK
      globenewswire.com
      • Nov. 4, 2025
  
    
  
  ATLANTA--(BUSINESS WIRE)--NCR Atleos Corporation (NYSE: NATL) (“Atleos”), a leader in expanding self-service financial access for financial institutions, retailers and consumers, has collaborated with Kuwait Finance House (KFH) to transform the in-branch customer experience through the deployment of a hyper-realistic conversational AI-powered avatar. This groundbreaking initiative introduces AI-driven video avatars at account service kiosks across KFH branches, offering customers real-time, per.
  
      NCR
      businesswire.com
      • Nov. 4, 2025
  
    
  
  LONDON--(BUSINESS WIRE)--COOL COMPANY Ltd. (“CoolCo” or the “Company”) (NYSE: CLCO / CLCO.OL) has announced today that it has established a record date of November 13, 2025 for a special meeting of its shareholders. At the special meeting, the date of which will be announced in due course, the Company's shareholders will vote on the previously announced proposed merger of CoolCo with a newly formed, wholly owned subsidiary of EPS Ventures Ltd. CoolCo shareholders of record at the close of busin.
  
      CLCO
      businesswire.com
      • Nov. 4, 2025
  
    
  
  GENEVA--(BUSINESS WIRE)--Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders.
  
      ALC
      businesswire.com
      • Nov. 4, 2025
  
    
  
  Global X Defense Tech ETF has surged over 80% YTD, outperforming legacy defense ETFs like ITA due to its unique composition and global focus. SHLD excels by emphasizing tech-driven defense, broader geographic exposure—especially Europe—and a more diversified, growth-oriented portfolio than ITA. Despite higher fees and volatility, SHLD benefits from Europe's unprecedented rearmament cycle and the fusion of traditional and tech defense sectors.
  
      SHLD
      seekingalpha.com
      • Nov. 4, 2025
  
    
  
  HSBC CEO Georges Elhedery warns that revenue profiles do not justify massive AI investments. Both Elhedery and General Atlantic's William Ford stress that productivity benefits and revenue gains will take several years.
  
      HSBC
      cnbc.com
      • Nov. 4, 2025
  
    
  
  Ted Pick, Chairman and CEO of Morgan Stanley, discusses the bank's business strategy in Asia and the opportunities ahead. He speaks with David Ingles and Yvonne Man from the sidelines of the Hong Kong Monetary Authority's Global Financial Leaders' Investment Summit.
  
      MGHL
      youtube.com
      • Nov. 4, 2025
  
    
  
  Starbucks has announced it is selling a 60% stake in its China operations to private equity firm Boyu Capital in a deal valued at $4 billion, a strategic overhaul designed to navigate intense local competition and fuel future growth in what has become its second-largest market.
  
      SBUX
      invezz.com
      • Nov. 4, 2025
  
    
  
  NEW YORK--(BUSINESS WIRE)--IMAX Corporation (NYSE: IMAX) (“IMAX”) today announced the pricing of $220,000,000 aggregate principal amount of 0.75% convertible senior notes due 2030 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and pursuant to exemptions from the prospectus requirements of applicable Canadian securities laws. The issuance and sale of the notes are scheduled to settle.
  
      IMAX
      businesswire.com
      • Nov. 4, 2025
  
    
  
  Toronto, Ontario--(Newsfile Corp. - November 4, 2025) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces that it has terminated a royalty agreement announced October 1, 2025 (the "Royalty Agreement) and entered into a loan agreement dated November 3, 2025 (the "Loan Agreement") with current debt lenders to the Company (the "Lenders") for aggregate funding of $512,000. A copy of the Loan Agreement has been filed by the Company on SEDAR+.
  
      EKG
      newsfilecorp.com
      • Nov. 4, 2025
  
    
  
  Acuitas Investments acquired 105,281 shares of Mechanics Bancorp, estimated to be worth about $5.10 million based on the average share price during Q3 2025. Post-trade, Acuitas Investments' stake totaled 105,281 shares valued at $5.10 million as of September 30, 2025.
  
      TBBK
      fool.com
      • Nov. 4, 2025